ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Otonomy Inc

Otonomy Inc (OTIC)

0.077
0.00
(0.00%)
Closed 09 February 8:00AM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.077
Bid
0.0757
Offer
0.0777
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.077
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

OTIC Latest News

Otonomy Announces Change in Stock Exchange Listing

SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq...

Otonomy Provides Corporate Update

SAN DIEGO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that the company’s board of directors, after considering strategic options, has approved and adopted a...

Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported...

Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss

Higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baselineLack of activity compared to 0.3 mg dose evaluated in prior studies may be due to a...

Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus

OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue development of OTO-313 and implement other...

Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and bilateral dosing of OTO-313 with top-line...

Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...

Otonomy to Participate in the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...

Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting

SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...

Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update

Positive top-line results announced for OTO-413 Phase 2a in hearing loss; enrollment ongoing for higher dose evaluationOTO-313 Phase 2 trial in tinnitus fully enrolled with top-line results...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

OTIC - Frequently Asked Questions (FAQ)

What is the current Otonomy share price?
The current share price of Otonomy is US$ 0.077
What is the 1 year trading range for Otonomy share price?
Otonomy has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
780.46M
CDTConduit Pharmaceuticals Inc
US$ 2.831
(82.65%)
140.32M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
215.16M
TOIIWOncology Institute Inc
US$ 0.033
(58.88%)
7.27k
CYTHCyclo Therapeutics Inc
US$ 1.19
(54.55%)
72.39M
FTELFitell Corporation
US$ 2.70
(-57.01%)
2.3M
SGBXSafe and Green Holdings Corporation
US$ 0.6401
(-44.82%)
5.65M
NKLANikola Corporation
US$ 0.4432
(-41.10%)
52.44M
PLRXPliant Therapeutics Inc
US$ 7.785
(-34.85%)
6.44M
LIPOLipella Pharmaceuticals Inc
US$ 3.08
(-33.76%)
2.2M
MGOLMGO Global Inc
US$ 0.4191
(126.54%)
780.46M
RIMEAlgorhythm Holdings Inc
US$ 0.0169
(-20.66%)
262.79M
GSIWGarden Stage Ltd
US$ 0.79
(78.73%)
215.16M
BHATBlue Hat Interactive Entertainment Technology
US$ 0.0537
(14.74%)
210.78M
NVDANVIDIA Corporation
US$ 129.84
(0.90%)
209.04M

Discussion

View Full Feed
cantwate cantwate 4 minutes ago
Do you mean the website that hasn't been updated in 2 years and still has the 2 Board members who resigned over a year ago as current members?

The cost to host a website typically ranges from $2 to $500 per month depending on the type of hosting plan you choose, with shared hosting be
IPIX
BBANBOB BBANBOB 5 minutes ago
PLus ya can't Pause it and run pee or grab a drink or a snack and lines at the drinks snacks and bathrooms are unreal at games
zandant zandant 6 minutes ago
Sadly, for some, having lost so much money has blinded them from reality.
IPIX
WALLnut WALLnut 6 minutes ago
You’re either misunderstanding or intentionally misrepresenting how FDA meetings work. Yes, the company requests the meetings, but the FDA grants them when they see value in discussion. These meetings aren’t ‘optional wastes of time’—they are an established part of the regulatory process, especially
RDGL
SC8 SC8 6 minutes ago
Just sticking to the facts. FDA doesn't request meetings. All these endless meetings have been solely at MK's request.
RDGL
Golden Cross Golden Cross 6 minutes ago
$LITM Snow Lake Energy Secures Funding to Advance Uranium Exploration, Supporting Nuclear Energy's Critical Role in Powering AI Data Centers
https://finance.yahoo.com/news/snow-lake-energy-secures-funding-144700823.html
LITM
janice shell janice shell 6 minutes ago
You are unfortunately correct. And he doesn't even do anything for the culties. Unless, of course, they're already rich and influential.
Golden Cross Golden Cross 7 minutes ago
$LITM Snow Lake Energy Secures Funding to Advance Uranium Exploration, Supporting Nuclear Energy's Critical Role in Powering AI Data Centers
https://finance.yahoo.com/news/snow-lake-energy-secures-funding-144700823.html
LITM
chereb19 chereb19 7 minutes ago
Criticizing an 80% tumor size reduction as a failure in a Phase 1 trial completely misinterprets the trial's purpose. In fact, achieving any significant tumor shrinkage in this early stage is an unexpected and promising outcome, not a failure. “the primary intent of Phase 1 studies is not to demonst
RDGL
Myth Myth 7 minutes ago
Elton John - Runaway Train ft. Eric Clapton

https://www.youtube.com/watch?v=d2FUj5A80gs
janice shell janice shell 8 minutes ago
lol, I was introduced to it in the early '60s, when my family moved to northwestern Indiana. There was a great bakery in town. And then when I went off to college, whenever someone had a birthday, we bought the Sara Lee version, which was pretty good.

In the '70s, it disappeared, at l
Sheepdog Sheepdog 8 minutes ago
This tells me GCAN CEO is smarter than people think....Well....obviously. People still buy this scam stock of his thinking it is a real company.

Of course that doesn't apply to those who know it is a scam and pump it anyway to try to profit off of the scam like Aitan. They are mar
GCAN
SC8 SC8 8 minutes ago
Again, no safety conclusions be made if these patients treated tumors didn't receive a kill dose of Radiogel. MK has only mentioned one patient so far, and PET scan at 30 days post treatment still showed living cancer fermenting labeled glucose. MK is again making unsubstantiated claims, something
RDGL
Golden Cross Golden Cross 9 minutes ago
$LITM Why LITM Is a Good Stock to Consider Adding to Your Portfolio
Good Read: https://allcapresearch.com/f/why-litm-is-a-good-stock-to-consider-adding-to-your-portfolio
LITM
somberfox somberfox 9 minutes ago
I dont think hes ever held a job.
RONN
zandant zandant 9 minutes ago
What website hosting are your referring to? Certainly not that abandoned company website that still includes the resigned board members and Jane "Asleep at the Wheel" Harness as part of senior management...along with a slew of misinformation. Ehrlich the Awful has gone into a cocoon.
IPIX
Golden Cross Golden Cross 9 minutes ago
$LITM Why LITM Is a Good Stock to Consider Adding to Your Portfolio
Good Read: https://allcapresearch.com/f/why-litm-is-a-good-stock-to-consider-adding-to-your-portfolio
LITM
kayak_wench kayak_wench 9 minutes ago
King was right, it was MUST READ!!!!
But for those that can't comprehend lawyer speak here is the translation by Chat GPT that clearly shows why this letter is so very important.

This letter concerns a patent infringement case between Purdue Pharma and Elite Pharmaceuticals re
ELTP
janice shell janice shell 10 minutes ago
Ahhh, I see.
jay_tee jay_tee 10 minutes ago
I've been here since 2017 you azz
RNVA
trader_ron trader_ron 11 minutes ago
Big Big BIG News coming 
RITE
MrMike241 MrMike241 11 minutes ago
The last German Chocolate cake I had, about 20 years ago, was dry and crumbly with a "frosting" that was way too sweet. But, I still ate it up 😁
Sheepdog Sheepdog 11 minutes ago
Do you know which institutions they have been committed to? They can't be in the institution voluntarily, because they have no money to pay for it anymore.

Naw, never mind....don't tell anyone which institutions. They have been punished enough by Roger for supporting his lies and tha
FUNN

Your Recent History

Delayed Upgrade Clock